AstraZeneca Viet Nam wins BritCham special award

The GREAT Awards program, organized annually by BritCham, recognises excellence and rewards organisations and individuals who have made significant contributions to the business environment in Viet Nam. A wide cross section of sectors are represented including education, technology, banking, health, and science, to name but a few. 

Mr. Nitin Kapoor, Chairman and General Director of AstraZeneca Viet Nam and Asia Area Frontier Markets, said: "As a global biopharmaceutical company with British-Swedish heritage and nearly three decades accompanying Viet Nam's health system, we are driven by a shared purpose to build a healthier future and make a lasting impact through innovation and sustainability. We are immensely proud to contribute to the UK-Viet Nam partnership and will continue to bring the advances of Britain's life sciences industry to create positive change for the people in Viet Nam."

AstraZeneca was ranked number 1 in Invention of Idea Pharma's 2023 Pharmaceutical Innovation and Invention Index, and has been the leader in terms of industry-sponsored clinical trials in Viet Nam. Out of the US$360 million (VND8.5 trillion) that AstraZeneca has committed to invest in Viet Nam until 2030, a significant amount has been dedicated to research and development to further strengthen the country's research capabilities and increase patients' early access to new medicines. 

AstraZeneca's innovative medicines have improved the lives of millions of Vietnamese patients with non-communicable diseases, while its COVID-19 vaccine played an important role in Viet Nam's fight against the pandemic.

In addition, AstraZeneca Viet Nam's commitment to sustainability is evident in its initiatives to promote access to healthcare, protect the environment, and uphold ethics and transparency. As part of the company's impactful partnerships with the Ministry of Health and healthcare organisations, AstraZeneca has run various community investment programmes to promote disease awareness, prevention, and early detection.

In order to support Viet Nam's sustainable development and net zero strategy, AstraZeneca recently announced a US$50 million investment into Viet Nam to plant 22.5 million trees over the next five years, as part of the company's global AZ Forest programme. 

This project will help to restore Viet Nam's forests and landscapes, allowing biodiversity to flourish, and providing sustainable livelihoods for over 17,000 smallholder farmers, alongside other co-benefits for the economy, communities, and environment.

This award adds to the extensive list of recognition that AstraZeneca has received in its long-standing collaboration with Viet Nam. The company's contributions to vaccine diplomacy, the fight against COVID-19, and advancements in cancer treatment and disease awareness programmes have earned certificates of merit from the Prime Minister and Minister of Health. 

Additionally, AstraZeneca has been recognized as one of Viet Nam's Top 100 Best Places to Work for four consecutive years.